• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High Rate of Inappropriate Fecal Immunochemical Testing at a Large Veterans Affairs Health Care System.大型退伍军人事务医疗保健系统中粪便免疫化学检测不当的高发生率。
Fed Pract. 2021 Jun;38(6):270-275. doi: 10.12788/fp.0142.
2
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
3
4
5
6
Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.结直肠癌筛查中粪便免疫化学试验阳性患者行结肠镜随访的障碍。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):469-476. doi: 10.1016/j.cgh.2018.05.022. Epub 2018 May 29.
7
Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.在结直肠癌筛查中,一次性结肠镜检查与一次性乙状结肠镜检查和多次邮寄粪便免疫化学检测的诊断收益比较。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):667-675.e1. doi: 10.1016/j.cgh.2019.08.015. Epub 2019 Aug 13.
8
Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.无症状粪便免疫化学检测阳性患者的腺瘤检出率。
Dig Dis Sci. 2018 May;63(5):1167-1172. doi: 10.1007/s10620-018-4984-9. Epub 2018 Feb 22.
9
Low Rate of Cancer Detection by Colonoscopy in Asymptomatic, Average-Risk Subjects with Negative Results From Fecal Immunochemical Tests.在粪便免疫化学检测结果为阴性的无症状、平均风险受试者中,结肠镜检查的癌症检出率较低。
Clin Gastroenterol Hepatol. 2020 Dec;18(13):2929-2936.e1. doi: 10.1016/j.cgh.2020.01.029. Epub 2020 Jan 31.
10
Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.粪便免疫化学试验为基础的结直肠癌筛查项目中结肠镜检查相关死亡率。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1418-1425. doi: 10.1016/j.cgh.2020.07.066. Epub 2020 Aug 7.

引用本文的文献

1
Delays in Diagnostic Colonoscopy After Positive FIT in an Integrated Healthcare System.综合医疗系统中粪便免疫化学试验呈阳性后诊断性结肠镜检查的延迟情况。
Dig Dis Sci. 2025 Mar;70(3):991-995. doi: 10.1007/s10620-025-08848-9. Epub 2025 Jan 22.
2
Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes.不适当的多靶点粪便DNA用于结直肠癌筛查:风险、依从性和结果
Cureus. 2023 Jun 16;15(6):e40506. doi: 10.7759/cureus.40506. eCollection 2023 Jun.

本文引用的文献

1
Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial.数字健康干预对脆弱患者接受结直肠癌筛查的影响:一项随机对照试验。
Ann Intern Med. 2018 Apr 17;168(8):550-557. doi: 10.7326/M17-2315. Epub 2018 Mar 13.
2
Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.粪便免疫化学试验阳性者参加结直肠癌筛查项目的口腔和上消化道癌症风险。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1237-1243.e2. doi: 10.1016/j.cgh.2018.01.037. Epub 2018 Feb 7.
3
Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.医生告知患者未坚持进行结直肠癌筛查对患者参与粪便免疫化学检测癌症筛查的影响:一项随机临床试验。
JAMA. 2017 Sep 5;318(9):816-824. doi: 10.1001/jama.2017.11387.
4
Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.结直肠癌筛查:美国多学会专家组关于结直肠癌筛查的医师和患者建议。
Gastroenterology. 2017 Jul;153(1):307-323. doi: 10.1053/j.gastro.2017.05.013. Epub 2017 Jun 9.
5
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.粪便检测结果呈阳性后至结肠镜检查的时间与结直肠癌风险及诊断时癌症分期之间的关联。
JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634.
6
Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers.结肠镜检查不依从者的结直肠癌死亡率与粪便血红蛋白浓度梯度之间的关联
J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw269.
7
Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.综合安全网系统中粪便免疫化学检测结果异常后诊断性结肠镜检查的利用不足
Am J Gastroenterol. 2017 Feb;112(2):375-382. doi: 10.1038/ajg.2016.555. Epub 2016 Dec 13.
8
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
9
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.四轮年度筛查中粪便免疫化学检测项目的表现:一项回顾性队列研究
Ann Intern Med. 2016 Apr 5;164(7):456-63. doi: 10.7326/M15-0983. Epub 2016 Jan 26.
10
Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.退伍军人健康管理局中潜在不适当的结直肠癌筛查率及其相关因素。
J Gen Intern Med. 2015 Jun;30(6):732-41. doi: 10.1007/s11606-014-3163-8. Epub 2015 Jan 21.

大型退伍军人事务医疗保健系统中粪便免疫化学检测不当的高发生率。

High Rate of Inappropriate Fecal Immunochemical Testing at a Large Veterans Affairs Health Care System.

作者信息

Gluskin Adam B, Dueker Jeffrey M, Khalid Asif

机构信息

is a Gastroenterology Fellow and and are Gastroenterologists at Veterans Affairs Pittsburgh Health Care System and the University of Pittsburgh Medical Center in Pennsylvania.

出版信息

Fed Pract. 2021 Jun;38(6):270-275. doi: 10.12788/fp.0142.

DOI:10.12788/fp.0142
PMID:34733074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8560050/
Abstract

INTRODUCTION

Colonoscopies and fecal immunochemical tests (FITs) are the preferred modalities for colorectal cancer (CRC) screening. In addition to proper patient selection, appropriate fecal immunochemical testing requires that negative tests be repeated annually, positive tests lead to a diagnostic colonoscopy, and FIT not be performed within 5 years of a colonoscopy with adequate bowel preparation. We sought to study the frequency of inappropriate FITs at the Veterans Affairs Pittsburgh Health Care System in Pennsylvania.

METHODS

A retrospective quality assurance study was undertaken of veterans undergoing FIT in a 3-year period (2015-2017). We calculated the rate of a negative initial FIT in 2015/2016 followed by a second FIT in 2016/2017 in a random selection of veterans (3% SE, 95% CI). Demographics were compared in an equal random number of veterans that did and did not have a follow-up FIT (5% SE, 95% CI of all negative FIT). We also calculated the rate of completing colonoscopy following a positive FIT in a random selection of veterans (3% SE, 95% CI). Finally, we investigated use of FIT following a colonoscopy for all veterans in the study period.

RESULTS

A total of 6,766 FITs were performed; 4,391 unique veterans had at least 1 negative FIT, and 709 unique veterans had a positive FIT. Of 1,742 veterans with at least 1 negative FIT, 870 were eligible for repeat testing during the study period, and only 543 (62.4%) underwent at least 2 FITs. There was no significant demographic difference in veterans that had only 1 or at least 2 FITs. Of 410 veterans with a positive FIT, 113 (27.5%) did not undergo a subsequent colonoscopy within 1 year due to patient refusal, or failure to schedule or keep a colonoscopy appointment. Of 832 veterans who had both a FIT and colonoscopy in the interval, 108 veterans underwent colonoscopy with a subsequent FIT (1.6% of total FITs performed). Of these, 95 (88%) were judged to be inappropriate. Thirteen instances of FIT following colonoscopy were appropriate based on patient preference to undergo fecal immunochemical testing for CRC screening modality after undergoing colonoscopy with an inadequate bowel preparation.

CONCLUSIONS

Veterans underwent inappropriate testing due to failure to undergo serial FIT after a negative result (37.6%), failure to complete colonoscopy following a positive FIT (27.5%), and undergoing inappropriate FIT following a recent colonoscopy (88%). Efforts are still required to improve both patient and provider education and adherence to appropriate fecal immunochemical testing and CRC screening guidelines.

摘要

引言

结肠镜检查和粪便免疫化学检测(FIT)是结直肠癌(CRC)筛查的首选方式。除了正确选择患者外,适当的粪便免疫化学检测要求阴性检测结果需每年重复进行,阳性检测结果需进行诊断性结肠镜检查,且在进行了充分肠道准备的结肠镜检查后5年内不得进行FIT。我们试图研究宾夕法尼亚州匹兹堡退伍军人事务医疗系统中不适当FIT检测的频率。

方法

对在3年期间(2015 - 2017年)接受FIT检测的退伍军人进行回顾性质量保证研究。我们计算了2015/2016年首次FIT检测为阴性,随后在2016/2017年进行第二次FIT检测的退伍军人的比例(3%标准误,95%置信区间)。对随机选择的有和没有进行后续FIT检测的相同数量退伍军人的人口统计学特征进行了比较(所有阴性FIT检测的5%标准误,95%置信区间)。我们还计算了随机选择的退伍军人中FIT检测呈阳性后完成结肠镜检查的比例(3%标准误,95%置信区间)。最后,我们调查了研究期间所有退伍军人在结肠镜检查后FIT检测的使用情况。

结果

共进行了6766次FIT检测;4391名不同的退伍军人至少有1次FIT检测结果为阴性,709名不同的退伍军人FIT检测结果为阳性。在1742名至少有1次FIT检测结果为阴性的退伍军人中,870名在研究期间符合重复检测条件,但只有543名(62.4%)进行了至少2次FIT检测。仅进行1次或至少进行2次FIT检测的退伍军人在人口统计学特征上没有显著差异。在410名FIT检测结果为阳性的退伍军人中,113名(27.5%)由于患者拒绝、未能安排或未遵守结肠镜检查预约,在1年内未进行后续结肠镜检查。在该时间段内同时进行了FIT检测和结肠镜检查的832名退伍军人中,108名退伍军人在结肠镜检查后进行了FIT检测(占总FIT检测次数的1.6%)。其中,95名(88%)被判定为不适当。基于患者在结肠镜检查肠道准备不充分后更倾向于采用粪便免疫化学检测作为CRC筛查方式,有13例结肠镜检查后的FIT检测是适当的。

结论

退伍军人由于FIT检测结果为阴性后未进行系列检测(37.6%)、FIT检测结果为阳性后未完成结肠镜检查(27.5%)以及近期结肠镜检查后进行了不适当的FIT检测(88%)而接受了不适当的检测。仍需努力提高患者和医疗服务提供者的教育水平,并使其遵守适当的粪便免疫化学检测和CRC筛查指南。